By binding to its G-protein-coupled receptors PKR1 and PKR2, PROK2 promotes chemotaxis and the release of pro-inflammatory cytokines, thus exacerbating the inflammatory response and tissue damage in COPD (80–82). The gene discussed is PROK2; the disease is chronic obstructive pulmonary disease.